Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.43 |
| ▸ | FDPS | P14324 | 4/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14840112 | 0.97 | TSHR (0.50) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL8156276 | 0.97 | DNM1 (0.48) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL5278296 | 0.97 | TSHR (0.50) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL11505412 | 0.97 | TSHR (0.50) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL2220069 | 0.97 | TSHR (0.50) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL23111414 | 0.97 | TSHR (0.50) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL11505299 | 0.97 | TSHR (0.50) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL5275632 | 0.97 | TSHR (0.50) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL8653866 | 0.97 | TSHR (0.50) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL1276672 | 0.97 | TSHR (0.50) | OPRM1TSHRTHRBLMNADNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109642015-B | Method for producing polyisocyanurate plastics by means of phosphine catalysis | 科思创德国股份有限公司 | 2022-09-23 | — | — | CN | claimed |
| US-11279790-B2 | Process for producing polyisocyanurate plastics by means of phosphine catalysis | COVESTRO DEUTSCHLAND AG (DE) | 2022-03-22 | — | — | US | claimed |
| EP-3507321-B1 | PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS BY MEANS OF PHOSPHINE CATALYSIS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2022-03-02 | — | — | EP | claimed |
| EP-3507321-A1 | PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS BY MEANS OF PHOSPHINE CATALYSIS | Covestro Deutschland AG (DE) | 2019-07-10 | — | — | EP | claimed |
| US-20190202963-A1 | PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS BY MEANS OF PHOSPHINE CATALYSIS | COVESTRO DEUTSCHLAND AG (DE) | 2019-07-04 | — | — | US | claimed |
| WO-2018041800-A1 | PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS BY MEANS OF PHOSPHINE CATALYSIS | COVESTRO DEUTSCHLAND AG (DE) | 2018-03-08 | — | — | WO | claimed |
| US-20040110915-A1 | for production of polyurethanes via catalytic polymerization with trimethylphosphine; improved storage stability | BAYER AKTIENGESELLSCHAFT (DE) | 2004-06-10 | — | — | US | claimed |
| US-12492281-B2 | Polyisocyanurate materials as electrical potting compounds | COVESTRO DEUTSCHLAND AG (DE) | 2025-12-09 | — | — | US | disclosed |
| CN-119978198-A | Reactive branched isobutenyl quaternary phosphonium salt copolymer, preparation method thereof and antibacterial coating | 中国石油化工股份有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119978199-A | Reactive branched isobutylene-based composite cationic salt copolymer, preparation method thereof and antibacterial coating | 中国石油化工股份有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119978201-A | Curable reactive branched isobutenyl quaternary phosphonium salt polymer, preparation method thereof, curable epoxy resin composition and waterproof and antifouling coating | 中国石油化工股份有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119978200-A | Curable reactive branched isobutenyl cationic salt copolymer, preparation method, curable epoxy resin composition and water-resistant mildew-proof coating | 中国石油化工股份有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-113631545-B | Polyisocyanurate materials as electrical potting compounds | 科思创德国股份有限公司 | 2025-01-07 | — | — | CN | disclosed |
| US-20140301970-A1 | VITAMIN FUNCTIONALIZED GEL-FORMING BLOCK COPOLYMERS FOR BIOMEDICAL APPLICATIONS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2014-10-09 | — | — | US | disclosed |
| US-20140301967-A1 | ANTIMICROBIAL CATIONIC POLYCARBONATES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2014-10-09 | — | — | US | disclosed |
| US-8058382-B2 | Uretdione formation in solution | BAYER MATERIALSCIENCE AG (DE) | 2011-11-15 | — | — | US | disclosed |
| US-20060173152-A1 | Uretdione formation in solution | BAYER MATERIALSCIENCE AG | 2006-08-03 | — | — | US | disclosed |
| EP-1683818-A2 | Uretdione formation in solution | Bayer MaterialScience AG (DE) | 2006-07-26 | — | — | EP | disclosed |
| US-20040110915-A1 | for production of polyurethanes via catalytic polymerization with trimethylphosphine; improved storage stability | BAYER AKTIENGESELLSCHAFT (DE) | 2004-06-10 | — | — | US | disclosed |
| EP-1426393-A2 | Low monomer urethdione-groups containing polyisocyanates | Bayer MaterialScience AG (DE) | 2004-06-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140301967-A1 | ANTIMICROBIAL CATIONIC POLYCARBONATES | VDR, GC, CYP24A1 | OPRM1 3511/4885TSHR 4067/4885THRB 3810/4885 |
| US-20140301970-A1 | VITAMIN FUNCTIONALIZED GEL-FORMING BLOCK COPOLYMERS FOR BIOMEDICAL APPLICATIONS | VDR, PROC, CYP24A1 | OPRM1 2256/4885TSHR 4511/4885THRB 2554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.